The present work shows that the corticotropin-releasing factor (CRF)-releasing activity of interleukin-1 (IL-1) is partially inhibited by a phospholipase A 2 (mepacrine) or a cyclooxygenase (indomethacin) inhibitor, but is not affected by inhibition of the lypooxygenase pathway with norhydroguaiaretic acid. These results indicate that the metabolism of arachidonic acid plays an important role as mediator of the effects of IL-1 on CRF release. It is also shown that products of the cyclooxygenase activity such as prostaglandins can stimulate CRF secretion by a direct action on the hypothalamus. Whereas PGE 2 failed to induce increases on CRF release, PGF2~ stimulated in a dose-dependent manner (21-340 nM), the CRF release from continuous perifused hypothalami. It is suggested that PGF2~ could be involved as a messenger in the hypothalamic CRF secretion induced by IL-1.
Introduction
There is considerable evidence indicating a bidirectional communication between the immune and central nervous system (Ballieux and Heijnen, 1987; Dantzer and Kelly, 1989; Ader, 1990) . The hypothalamic-pituitary-adrenal (H-P-A) axis plays an important role in the relationship between the immune and neuroendocrine systems (Bateman et al., 1989) . The interleukins (ILs), cytokines essential for the immune reCorrespondence to: C. Guaza, Department of Psychobiology, Cajal Institute, CSIC, Doctor Arce 37, 28002 Madrid, Spain.
sponse (Claman, 1987) , appear to play an important role in this neur.oimmune communication. lnterleukin-1, a monokine which activates T-cell proliferation (Dinarello, 1989) , has a potent activating effect on the H-P-A axis, increasing plasma concentrations of adrenocorticotropic hormone (ACTH) and corticosterone (Bateman et al., 1989; Dunn, 1990; Schettini, 1990) . Most evidence indicates a hypothalamic site of IL-1 action, inducing corticotropin-releasing factor (CRF) secretion.
Arachidonic acid metabolites or eicosanoids are lipid autocoids which modulate a great number of cell functions in many cell types (Johnson et al., 1983) . Arachidonic acid (AA) is metabolized by two distinct oxygenase pathways with
